9WA-26638-94151
3 vaccinations
4 coded responses
18 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 329 / FL
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Dose 1 — Pfizer-BioNTech
-
2021-02-02
Dose 2 — Pfizer-BioNTech
-
2021-02-03
Registered in v-safe
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
-
2021-03-02
Survey response — day 28, dose 2MedDRA: Diplopia, Headache, Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Sudden diplopia, nausea, mild-mod headache on 2/26/21 lasting 2 hours then gradual return to normal over next 1-2 hrs. Not as bad as episode after first vaccination. No residual. No repeat. No others symptoms. Rested on couch until passed.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-09
- 2021-03-16
-
2021-05-04
Survey response — 3 months, dose 2MedDRA: Fatigue, Headache — Feeling: GoodFree text: Headache, mild fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-03
Survey response — 6 months, dose 2MedDRA: Diarrhoea, Dizziness, Fall, Gait disturbance, Malaise, Self-medication — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Dizziness, gait instability sans falls, diarrhea , general malaise, all lasting 2-3 days, longer for the dizziness. Improved with naproxen.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-03
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-14
-
2021-12-28
Dose 3 — Pfizer-BioNTech
- 2022-02-02
-
2022-02-02
Survey response — day 35, dose 3MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: More headaches, and I NEVER had headaches previouslyMedDRA releases: 2024-11 · check-in free text available
- 2022-02-08
- 2022-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-12-28 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — day 28, dose 2
Symptoms: Sudden diplopia, nausea, mild-mod headache on 2/26/21 lasting 2 hours then gradual return to normal over next 1-2 hrs. Not as bad as episode after first vaccination. No residual. No repeat. No others symptoms. Rested on couch until passed.
Release 8 — 3 months, dose 2
Symptoms: Headache, mild fatigue
Release 9 — 6 months, dose 2
Symptoms: Dizziness, gait instability sans falls, diarrhea , general malaise, all lasting 2-3 days, longer for the dizziness. Improved with naproxen.
Release 11 — day 35, dose 3
Symptoms: More headaches, and I NEVER had headaches previously
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | · | ✓ |
| SD | Diplopia | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | · | ✓ |
| SD | Fall | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gait disturbance | ✓ | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Malaise | ✓ | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release